{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T01:36:04Z","timestamp":1765157764010,"version":"build-2065373602"},"reference-count":33,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2012,11,15]],"date-time":"2012-11-15T00:00:00Z","timestamp":1352937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Human papillomavirus (HPV) 52 is an oncogenic HPV type prevalent in Asia. The aim of the study was to analyze HPV 52 genetic variations in women from Northeast China. To explore the intratypic variants of HPV 52, the genomic regions of L1, E6, E7 and long control region (LCR) of HPV 52, which have been identified in women from Northeast China by HPV GenoArray test, were analyzed. Twenty-five mutations were identified in the regions examined. Of the mutations found in the L1 gene, three novel nonsynonymous mutations of C5640T, A5641T and G5642A were located within the region that encodes the binding domain of neutralizing antibodies against HPV 52. Although four variations were identified in HPV 52 E6 and E7 genes, no significant association was found between the mutations and the cytological lesion of the patients. Eight mutations, including a novel CTT7681\u20137683 deletion, found in the LCR of HPV 52 encompassed the known transcription binding sites, which may possibly affect the transcription of the oncogenic genes of E6 and E7. The most prevalent HPV 52 variant in women from northeastern China belongs to clade L1-LN-A. The genetic variations of HPV 52, including three novel nonsynonymous mutations of C5640T, A5641T and G5642A in the L1 gene and a novel CTT7681\u20137683 deletion in the LCR, were first documented in strains from women in Northeast China. The statistical result showed no associations between the variants and the severities of the infected women. These findings provide new data regarding gene variations of HPV 52.<\/jats:p>","DOI":"10.3390\/ijms131114962","type":"journal-article","created":{"date-parts":[[2012,11,15]],"date-time":"2012-11-15T11:03:44Z","timestamp":1352977424000},"page":"14962-14972","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Genomic Polymorphism of Human Papillomavirus Type 52 in Women from Northeast China"],"prefix":"10.3390","volume":"13","author":[{"given":"Zhengrong","family":"Sun","sequence":"first","affiliation":[{"name":"Virus Laboratory, The Affiliated Shengjing Hospital, China Medical University, Heping District, Shenyang 110004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhitao","family":"Lu","sequence":"additional","affiliation":[{"name":"Virus Laboratory, The Affiliated Shengjing Hospital, China Medical University, Heping District, Shenyang 110004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Liu","sequence":"additional","affiliation":[{"name":"Virus Laboratory, The Affiliated Shengjing Hospital, China Medical University, Heping District, Shenyang 110004, China"},{"name":"Department of clinical laboratory, The Affiliated Shengjing Hospital, China Medical University, Heping District, Shenyang 110004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guili","family":"Wang","sequence":"additional","affiliation":[{"name":"Virus Laboratory, The Affiliated Shengjing Hospital, China Medical University, Heping District, Shenyang 110004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqiang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Virus Laboratory, The Affiliated Shengjing Hospital, China Medical University, Heping District, Shenyang 110004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianxia","family":"Yang","sequence":"additional","affiliation":[{"name":"Virus Laboratory, The Affiliated Shengjing Hospital, China Medical University, Heping District, Shenyang 110004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[{"name":"Virus Laboratory, The Affiliated Shengjing Hospital, China Medical University, Heping District, Shenyang 110004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Ruan","sequence":"additional","affiliation":[{"name":"Virus Laboratory, The Affiliated Shengjing Hospital, China Medical University, Heping District, Shenyang 110004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2012,11,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens. Part B. Biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet. Oncol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/sj.bjc.6603450","article-title":"Human papillomavirus infection in Shenyang city, People\u2019s Republic of China: A population-based study","volume":"95","author":"Li","year":"2006","journal-title":"Br. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1349-7006.2009.01161.x","article-title":"Human papillomavirus infections among Japanese women: Age-related prevalence and type-specific risk for cervical cancer","volume":"100","author":"Onuki","year":"2009","journal-title":"Cancer Sci"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijgo.2009.11.026","article-title":"Characteristic of HPV prevalence among women in Liaoning province, China","volume":"109","author":"Sun","year":"2010","journal-title":"Int. J. Gynaecol. Obstet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1155\/2007\/914823","article-title":"The epidemiology of human papillomavirus infection and cervical cancer","volume":"23","author":"Bosch","year":"2007","journal-title":"Dis. Markers"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0950-3552(05)80357-8","article-title":"Epidemiology of cervical intraepithelial neoplasia: The role of human papillomavirus","volume":"9","author":"Cox","year":"1995","journal-title":"Baillieres Clin. Obstet. Gynaecol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ijc.2910610305","article-title":"The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months","volume":"61","author":"Remmink","year":"1995","journal-title":"Int. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1158\/1055-9965.EPI-05-0864","article-title":"Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant","volume":"15","author":"Grodzki","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1590\/S0100-879X2006000600002","article-title":"Epidemiological and functional implications of molecular variants of human papillomavirus","volume":"39","author":"Sichero","year":"2006","journal-title":"Braz. J. Med. Biol. Res"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1128\/jvi.69.12.7743-7753.1995","article-title":"Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments","volume":"69","author":"Yamada","year":"1995","journal-title":"J. Virol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/viro.2000.0702","article-title":"HPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16","volume":"279","author":"Pastrana","year":"2001","journal-title":"Virology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.virusres.2007.08.003","article-title":"Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression","volume":"131","author":"Lee","year":"2008","journal-title":"Virus Res"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1128\/JVI.79.10.5914-5922.2005","article-title":"Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle","volume":"79","author":"Hubert","year":"2005","journal-title":"J. Virol"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.bjc.6600024","article-title":"Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: Implications for cervical disease","volume":"86","author":"Kammer","year":"2002","journal-title":"Br. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1128\/JCM.43.7.3260-3266.2005","article-title":"Comparison between the hybrid capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia","volume":"43","author":"Rymark","year":"2005","journal-title":"J. Clin. Microbiol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine inprevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N. Engl. J. Med"},{"key":"ref_20","unstructured":"(2007). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/ijc.22481","article-title":"High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18","volume":"120","author":"Sichero","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0304-3835(01)00570-5","article-title":"Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia\/cervical cancer in relation to their oncogenic potential","volume":"170","author":"Xin","year":"2001","journal-title":"Cancer Lett"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"13630","DOI":"10.1128\/JVI.79.21.13630-13640.2005","article-title":"Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35 52, and 58, four close relatives of human papillomavirus type 16","volume":"79","author":"Villa","year":"2005","journal-title":"J. Virol"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jmv.20259","article-title":"Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV-seropositive and HIV-seronegative women at risk for HIV infection","volume":"75","author":"Gagnon","year":"2005","journal-title":"Med. Virol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmv.21432","article-title":"Genetic variability and phylogeny of the high-risk HPV-31, \u221233, \u221235, \u221252, and \u221258 in central Brazil","volume":"81","author":"Raiol","year":"2009","journal-title":"J. Med. Virol"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ijc.25724","article-title":"Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia","volume":"129","author":"Chang","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1158\/0008-5472.CAN-09-4179","article-title":"A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia","volume":"70","author":"Schiffman","year":"2010","journal-title":"Cancer Res"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1086\/379198","article-title":"Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative women","volume":"188","author":"Aho","year":"2003","journal-title":"J. Infect. Dis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1128\/JVI.79.11.6741-6750.2005","article-title":"Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ygyno.2010.08.032","article-title":"Distribution of human papillomavirus 58 and 52 E6\/E7 variants in cervical neoplasia in Chinese women","volume":"119","author":"Ding","year":"2010","journal-title":"Gynecol. Oncol"},{"key":"ref_31","unstructured":"Available online: http:\/\/blast.ncbi.nlm.nih.gov\/Blast."},{"key":"ref_32","unstructured":"Available online: http:\/\/www.cbrc.jp\/research\/db\/TFSEARCH.html."},{"key":"ref_33","unstructured":"Available online: http:\/\/www.spss.com."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/13\/11\/14962\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:53:35Z","timestamp":1760219615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/13\/11\/14962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,15]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11]]}},"alternative-id":["ijms131114962"],"URL":"https:\/\/doi.org\/10.3390\/ijms131114962","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2012,11,15]]}}}